VARIANTS OF DR3 AND USE THEREOF

Amir Aharoni; Itay Levin

VARIANTS OF DR3 AND USE THEREOF

Amir Aharoni (Inventor), Itay Levin (Inventor)

Department of Life Sciences

Ben-Gurion University of the Negev

Research output: Patent

Abstract

Death-domain receptor 3 (DR3)variants having increased binding affinity to TL1A,and composition comprising same,are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.

Original language	American English
Patent number	CA2947255
IPC	A61P 29/ 00 A I
Priority date	27/04/15
State	Published - 5 Nov 2015

Cite this

@misc{7db23a6afa21411395dbf6c2b1739f37,

title = "VARIANTS OF DR3 AND USE THEREOF",

abstract = "Death-domain receptor 3 (DR3)variants having increased binding affinity to TL1A,and composition comprising same,are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.",

author = "Amir Aharoni and Itay Levin",

year = "2015",

month = nov,

day = "5",

language = "American English",

type = "Patent",

note = "CA2947255; A61P 29/ 00 A I",

}

TY - PAT

T1 - VARIANTS OF DR3 AND USE THEREOF

AU - Aharoni, Amir

AU - Levin, Itay

PY - 2015/11/5

Y1 - 2015/11/5

N2 - Death-domain receptor 3 (DR3)variants having increased binding affinity to TL1A,and composition comprising same,are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.

AB - Death-domain receptor 3 (DR3)variants having increased binding affinity to TL1A,and composition comprising same,are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.

M3 - Patent

M1 - CA2947255

ER -

VARIANTS OF DR3 AND USE THEREOF

Abstract

Fingerprint

Cite this